CEL-SCI Corp (CVM)

Currency in USD
1.450
-0.290(-16.67%)
Closed·
1.500+0.050(+3.45%)
·
Unusual trading volume
Trading near 52-week Low
CVM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.4401.820
52 wk Range
1.44013.477
Key Statistics
Prev. Close
1.74
Open
1.75
Day's Range
1.44-1.82
52 wk Range
1.44-13.477
Volume
838.33K
Average Volume (3m)
106.73K
1-Year Change
-80.011%
Book Value / Share
1.32
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.000
Upside
+1,624.14%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

CEL-SCI Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 25.000
(+1,624.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
17-02-2026
EPS / Forecast
-0.68 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CVM Income Statement

Compare CVM to Peers and Sector

Metrics to compare
CVM
Peers
Sector
Relationship
P/E Ratio
−0.5x−10.4x−0.5x
PEG Ratio
−0.01−0.050.00
Price/Book
1.1x5.1x2.6x
Price / LTM Sales
-202.0x3.2x
Upside (Analyst Target)
-78.3%48.3%
Fair Value Upside
Unlock−6.3%5.6%Unlock

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company’s lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company’s LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
381.14K4.71%552.66K
Other Institutional Investors
926.97K11.45%1.34M
Public Companies & Retail Investors
6.78M83.84%9.84M
Total
8.09M100.00%11.73M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lincoln Alternative Strategies Llc6.86%5,55,000805
The Vanguard Group, Inc.3.52%2,85,117413

FAQ

What Is the CEL-SCI (CVM) Share Price Today?

The CEL-SCI share price today is 1.450.

What is the current CEL-SCI (CVM) share price and day range?

As of 07-05-2026, the CEL-SCI share price is 1.450, with a previous close of 1.740. The share price has ranged from 1.440 to 1.820 today, while the 52-week range spans from 1.440 to 13.477.

What Is the CEL-SCI Market Cap?

As of today, CEL-SCI market cap is 11.730M.

What Is the CEL-SCI (CVM) Share Price Target?

The average 12-month share price target for CEL-SCI is 25.000, with a high estimate of 25 and a low estimate of 25. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +1,624.14% Upside potential.

What Is CEL-SCI's Earnings Per Share (TTM)?

The CEL-SCI EPS (TTM) is -4.317.

From a Technical Analysis Perspective, Is CVM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does CEL-SCI Trade On?

CEL-SCI is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for CEL-SCI?

The stock symbol for CEL-SCI is "CVM."

How Many Times Has CEL-SCI Stock Split?

CEL-SCI has split 4 times.

How Many Employees Does CEL-SCI Have?

CEL-SCI has 44 employees.

What Is the CVM Premarket Price?

CVM's last pre-market stock price is 1.789. The pre-market share volume is 3,800.000, and the stock has changed by 0.049, or 2.820%.

What Is the CVM After Hours Price?

CVM's last after hours stock price is 1.500, the stock has changed by 0.050, or 3.450%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.